TenderlineUK
Procurement Intelligence
Official OCDS
Find a Tender
complete
Official procurement procedure

Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis

Medical consumables
Other therapeutic products
Repair and maintenance services of medical equipment
UK
Published value
Not published
Submission deadline Not published
Lots published1
Procurement Executive Summary
AI & Search Synopsis
Generated from official OCDS record
Tenderline Synopsis: NHS Blood & Transplant: "Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis". Published status: complete. Published value: Value not published. 1 published lot. Submission deadline not published. See the official notice for participation instructions.
Contracting AuthorityNHS Blood & TransplantScope & CategoriesNot publishedSubmission Window
complete
No deadline published
Submission GatewayDirect notice routeLegal Basis & RegimeStandard procurementEstimated Value (exc. VAT)Not published
Bidder Intelligence · Authority Profile: NHS Blood & Transplant
Market Analytics
View Authority Profile →
Derived from OCDS awards & bid statistics
Published history for NHS Blood & Transplant. These figures describe retained records, not a forecast of bids or a measure of buyer bias.
Published-to-award variance
Not availableInsufficient comparable data
Requires at least 5 comparable procedures
Competition Density
1Bids / Report
100% of reports have one bid
Supplier ConcentrationNo estimate
Insufficient attributable awardsNo concentration estimate available
Payment Terms
Check noticePublished terms
Payment obligations depend on the applicable regime and contract. Consult the official documents.
Coverage: 4 active published awards; 4 bid reports (which may be per lot). Supplier values exclude multi-supplier awards, frameworks and DPS, and use GBP only. They are published award values, not payments. Published-to-award variance compares single-lot, single-award, single-supplier GBP procedures with explicitly non-framework/non-DPS status; increases remain in the average. Unpublished data stays unknown. Awarded suppliers are winners, not all bidders.
Procedure terms
Contracting AuthorityNHS Blood & Transplant
Procedure methodNot published
Procurement categoryNot published
Statuscomplete
Framework / DPSNot published
CompetitionNot published
Above thresholdNot published
Legal basisNot published
Tender period startsNot published
Clarification deadlineNot published
Electronic submissionNot published
Submission languagesNot published
Published11 Aug 2021, 16:14 BST
Last source update11 Aug 2021, 16:14 BST
Recurring procurementNot published
ClassificationMedical consumables, Other therapeutic products, Repair and maintenance services of medical equipment
Delivery area
UK
OCIDocds-h6vhtk-02d395
What is being bought
The award is for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887. Please see section II.2.4 for detailed description of the procurement.
What changed
From the official release history
  1. Status changed to complete
    11 Aug 2021, 16:14 BST
  2. Official notice release published
    11 Aug 2021, 16:14 BST
  3. Buyer information updated
    11 Aug 2021, 16:14 BST
Lots and requirements (1)
Published by the contracting authority
  • Lot 1 · #1
    Individual lot title not published
    cancelled
    Published valueNot published
    The Therapeutic Apheresis Services (TAS) function operates within the Clinical Services directorate of NHSBT. Multi-disciplinary TAS teams operate from eight regional hub units and three 3 spoke sites that are based within Acute NHS Trusts across England and South Wales. Each unit provides a portfolio of therapeutic treatments to both adult and paediatric patients from across a range of clinical specialities. Treatments provided include: Extracorporeal Photopheresis (ECP), Peripheral Blood Stem Cell (PBSC) Collection, Therapeutic Plasma Exchange (PEX), Red Cell Exchange (RCE), Low Density Lipid (LDL) Removal, Platelet / White Cell Depletion and Lymphocyte Collection. The requirement for this procurement was for the supply of consumables and maintenance of the existing ART Universal machines. Contract notice published on 10th March 2021 with publication reference: 2021/S 000-004887. As a result of the tender, a Framework Agreement for Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis for a period of 2 years with two 1-year options to extend has been awarded to Fresenius Medical Care (UK) Ltd.
    Contract periodNot published
    EligibilityNot published
    Options / renewalNot published
Timeline
  1. Procedure published
    11 Aug 2021, 16:14 BST
  2. Award active
    Not published · Not published
  3. Contract active
    Signed 1 Aug 2021, 00:00 BST · £99,500
Commercial outcome and competition
Awards
Fresenius Medical Care (UK) Ltd
Not published · Not published · active
Contracts
Support of existing NHSBT Low Density Lipid (LDL) Removal Apheresis
£99,500 · signed 1 Aug 2021, 00:00 BST · active
Bid statistics
bids: 1 (lot 1)
Buyer and organisations in this procedure

NHS Blood & Transplant

Contracting authority GB-FTS-20611
View buyer profile

  • NHS Blood & Transplant
    buyer

    500-600 North Bristol Park, Northway Bristol, Filton, BRISTOL, UK, BS347QH
    marta.drozdzowska@nhsbt.nhs.uk
    +44 1179217243

  • Fresenius Medical Care (UK) Ltd
    supplier

    Sutton-in-Ashfield, UK, NG17 2HU

  • NHS Blood and Transplant
    reviewBody

    Bristol
Documents (0)
Official links; attachments are not copied
No data
No linked documents are published
Related procedures (0)
No data
No related procedures published